Donald Trump is barnstorming the country to boost Republicans in the final weeks of the midterms. But many candidates want to keep that support quiet.
The president is nowhere...
RICHMOND, Virginia — Jay Jones, the Democratic Virginia attorney general hopeful whose violence-themed text messages triggered a nationwide GOP backlash, said during a Thursday...
Progressive "Squad" member Rep. Rashida Tlaib, D-Mich., has spent over $35,000 on luxury limousine services since last year, according to her most recent Federal Election Commission filings.
President Donald Trump unveiled plan to make IVF treatments more affordable, with fertility drug discounts of 42-79% depending on patient income levels.
Recent campaign attacks damaged both Mikie Sherrill and Jack Ciattarelli's favorability ratings as the New Jersey gubernatorial race tightens to a 5-point margin.
New Fox News survey shows Zohran Mamdani maintaining 21-point lead over Andrew Cuomo in NYC mayoral race as voters favor him on crime and housing issues.
The whistleblowers said they faced retaliation after they testified before Congress about misconduct by IRS and DOJ officials on the Hunter Biden tax case.
A day after the U.S. Supreme Court heard arguments in a significant redistricting case centering on Louisiana's congressional map, which has two majority-Black districts, Republican Gov. Jeff Landry announced that he is calling state lawmakers back to the Capitol to consider changes to next year's election schedule, plans and code.
President Trump announced a plan to make in vitro fertilization more accessible to American women with an employer benefit option to offer coverage of the treatments directly to their workers.
Solar proponents are melting down over a Trump administration move to curb the development of a solar mega project in Nevada that environmental groups said would threaten the sensitive ecosystem and blight one of the most intact remaining landscapes in the state.
Some of the largest pharmaceutical companies in the world this year are planning to announce an unprecedented $500 billion to bolster their American research and manufacturing amid President Trump's threat that drugmakers ramp up their domestic manufacturing or face steep tariffs.
